Description
Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially a
Table of Contents
Antibody-based Products. Anticoagulants. Antisense Based Products. Blood Factors. Bone Morphogenetic Proteins. Colony Stimulating Factors. Erythropoietin. Growth Factors. Hormones. Interferons. Interleukins, Tumour Necrosis Factor and Related Products. Therapeutic Enzymes. Thrombolytic agents. Vaccines.
